Introduction
Japan has low mortality from ischaemic heart disease (IHD) with moderate mortality from stroke and the longest life expectancy in the world. Recent changes in lifestyles may have considerable effects on cardiovascular risk factors. Blood pressure (BP) levels have decreased rapidly and serum cholesterol levels have been increasing. 1, 2 Reflecting changes in these risk factors, mortality rates from cardiovascular diseases (CVD) have changed rapidly. 3 During the years from 1969-70 to 1991-92, age-adjusted stroke mortality rate for 30-69 year olds has declined, 77% for men and 78% for women. 4 Prevalence of risk factors for Japanese are different from those in Western countries, but the relationship of the risk factors to cardiovascular incidence and mortality appears essentially the same as those in Western countries. [5] [6] [7] However, since the Japanese data are mainly from small cohorts in rural populations, comprehensive analysis of the effect of risk factors on CVD mortality and mortality from all causes has not been reported from large Japanese populations.
In 1980, the National Survey on Cardiovascular Diseases was conducted for participants randomly selected from the Japanese population. 8 Since the follow-up study of this representative population will usefully inform the public health policy of Japan, we used these data as the baseline for a retrospective cohort study with the cooperation of 300 public health centres that conducted the National Survey in 1980. We also conducted a survey of activities of daily living of the survivors aged 65 and above at the follow-up in 1994.
We examine the impact of elevated BP on mortality from all causes, CVD, heart disease and stroke.
Subjects and methods
In the National Survey on Cardiovascular Diseases in 1980, 300 zones were selected using the stratified random sampling method based on the national census in 1975. All residents aged 30 years or more in these zones were invited to this survey. A total of 10 558 participants aged 30 years or more (response rate: 78.5%) were examined with assessment of past and present history of hypertension, stroke and myocardial infarction. Body height and body weight was measured under light clothes and body mass index (BMI) was calculated by body weight (kg) divided by square of body height (m). BP and pulse rates were measured after a 5 min rest by trained public health nurses of each public health centre using a standard mercury sphygmomanometer. Frequency of drinking per week and average number of cigarettes per day were assessed using questionnaires. Serum total cholesterol levels were determined in a laboratory under the quality control programme of the Center for Disease Control in the United States. Casual blood sugar levels were determined in the same laboratory using the deoxidized method. Details of this survey are published elsewhere. 8 In 1994, we asked the 300 public health centres that took part in the 1980 National Survey to followup the original participants by their name and age in 1980, since these were recorded on the participant list. The public health centres reported date of birth, present address and date of death, if dead. We conducted the second follow-up survey for the participants for whom they could not obtain the information (n ¼ 2345). To identify the participants' address, we used telephone books and residential maps of 1980 stored in the National Library of Parliament. Using this method, we could follow-up 1135 (10.8%) of the original participants.
We requested registration records of the participants in the cities or towns where they lived. If the participants had moved out of the town, we requested their registration record from the cities or towns where they had moved to. We could get information on 9648 participants with a follow-up rate of 91.4%. We found 1327 deaths during the follow-up.
We used computerized vital statistics data to identify the underlying causes of deaths of the participants who died during the follow-up by date of birth, sex, date of death and area code of the place of death with the permission of the Management and Coordination Agency, Japan. Underlying causes of death were assigned centrally from death certificates according to the International Classification of Disease (ICD 9); (Stroke: 430-438, and heart disease: 410-429, CVD 390-459). We could identify the cause of death for 99.5% of the dead participants. Since the observed number of deaths from IHD were small (43 for men and 46 for women), we included these deaths in the heart disease category.
Participants were classified into six BP groups according to JNC-VI 9 (ie, I: SBPo120 mmHg and DBPo80 mmHg, II: SBPo130 mmHg and DBPo 85 mmHg, III: SBPo140 mmHg and DBPo90 mmHg, IV: SBPo160 mmHg and DBPo100 mmHg, V: SBPo180 mmHg and DBPo110 mmHg, VI: SBP ¼ 180 mmHg or more or DBP ¼ 105 mmHg or more). Participants with antihypertensive treatment of SBPo160 mmHg and DBPo100 mmHg, of SBPo180 mmHg and DBPo110 mmHg and of SBP ¼ 180 mmHg or more or DBP ¼ 110 mmHg were classified into IV, V and VI groups, respectively. Participants with diabetes were assigned by past history of diabetes and/or casual blood sugar ¼ 200 mg/dl or more.
To analyse CVD mortality associations, participants with a past history of myocardial infarction (AMI: n ¼ 45) or stroke (n ¼ 110) were excluded. For stroke analyses, participants with a past history of stroke were excluded and for heart disease analyses, participants with a past history of AMI were also excluded.
Statistical analysis
The person-year method of analysis was used and age-adjusted mortality rates were calculated according to the standard population of Japan in 1985. Ageadjusted relative risks and 95% confidence intervals were calculated using the Mantel-Haenszel procedure. The test for linear trends was used to test the overall relationship of blood pressure to mortality rate using the Cox proportional hazard model adjusting for age.
The Cox proportional hazard model was used to calculate multiadjusted relative risks of a BP category increase controlling for age, BMI, serum total cholesterol, presence of diabetes, smoking category and drinking category and then we calculated multiadjusted attributable risk for each BP category. We calculated percentage excess mortality as the product of the multi-adjusted attributable risk and percentage of the participants in the BP category.
Results
Overall follow-up rate was 91.4%; the rate was significantly lower in the 30-59 years group (90.1%) than for those of the X60 years group (92.4%, Po0.05). The number of participants who moved from the original address during the follow-up was 7.8% (9.1% for 30-59 year group and 4.0% for people 60 years or more, Po0.05). Table 1 shows the baseline characteristics of the participants according to BP levels for both sexes. The number of participants in Group IV was the most frequent for both sexes. Mean ages, SBP, DBP, serum total cholesterol and prevalence of antihypertensive treatment were significantly different among BP groups for both sexes. Prevalence of drinking and smoking was significantly different among BP groups among men while not significant for women. Table 2 shows the number of deaths and ageadjusted rates per 100 000 person-years for all causes and cause-specific mortality. Total observed person-years were 53 948 for men and 70 932 for women. For both sexes, age-adjusted mortality rates from all causes, CVD, heart disease and stroke, increased with BP levels. The mortality from all causes with severe hypertension (Group VI) was 1406 per 100 000 person-years for men and was similar to those for women (1327 per 100 000 person-years), while that in optimal BP level (Group I) was higher in men (790 per 100 000 person-years) than in women (432 per 100 000 person-years). As with the mortality rate from all causes, most increases in cause-specific mortality with increasing BP levels were clearer among men than in women. Table 3 shows the relative risks and 95-percent confidence interval of mortality from all causes and specific causes according to BP levels for men and women. Relative risk of death from all causes was significantly higher in Group VI for both sexes than in Group I, the test for linear trend shows significant relationship with BP levels and mortality from all causes for men (Po0.001) while not significant among women. Relative risk of mortality from CVD, heart disease and stroke increased significantly with BP levels among men. In women, the relative risk of CVD and stroke death similarly increased with BP levels. However, the relationship of heart disease mortality with BP levels was not clear. Table 4 shows the results of multiadjusted relative risk of a one-level increase of WHO category controlled for age, BMI, smoking habits, drinking habits, serum total cholesterol and presence of diabetes. For both sexes, BP levels were significantly related to mortality from all causes, CVD and stroke. However, the relationship of BP levels to heart disease mortality was different. For men, the relative risk for heart disease was significantly related to BP levels, while not among women.
These data show that elevated blood pressure is an independent risk factor for mortality from all causes as well as from cardiovascular diseases for Figure 1a and b show the percentage of excess stroke mortality (bar) calculated by multiadjusted relative risks (Table 4 ) and the prevalence of participants in the 1980 survey (lines) in each BP category for men and for women. The overall percentages of excess mortality of elevated BP considering the group I (optimal BP level) as reference group were 130% for men and 42% for women. Although relative risk was highest in the group VI (severe hypertension), the prevalence of this BP group was only 5.6% for men and 4.5% women. Thus, estimated excess stroke mortality was chiefly due to the group IV (mild hypertension) for both sexes: 48% for men and 16% for women.
Discussion

Major findings from this study
This is the follow-up study in Japan using the participants randomly selected in 300 districts throughout Japan in 1980 (NIPPON DATA 80). We analysed the comprehensive effect of elevated BP on mortality from stroke, heart disease, CVD and all causes of death using BP categories according to JNC-VI. 9 For men, elevated BP level was an independent risk factor for mortality from all causes as well as CVD, heart disease and stroke mortality before and after controlling for other major cardiovascular risk factors. For women, a significant relationship of BP levels to mortality from all causes, CVD and stroke was also observed but not for heart disease.
In the analysis of excess stroke mortality according to BP levels, the major contribution was from the group IV (mild hypertension) for both sexes rather than from the highest BP group. The prevalence of hypertension was much lower than that in 1965 survey (15% for men and 14% for women). 1 The observed relationships of elevated BP to CVD and stroke mortality are consistent with other studies. 5, 7, [10] [11] [12] [13] [14] The relative risks are relatively smaller than those from other studies in Japan. 5, 7, 14 These differences may be explained by the difference of the age of the target population, since this study includes older participants who are 80 years and above with smaller relative risk than the younger generation.
Design of this study
Although well-designed cross-sectional surveys can be used for the baseline data for the follow-up study, it is difficult to perform the follow-up with a high performance rate after 14 years. At the beginning of this study, we had information only on name, age and sex for the participants of the National Survey on Cardiovascular Disease in 1980. However, with the cooperation of most of the 300 public health centres involved in the original survey in 1980, we could get the date of birth, present address and, if the person was dead, date and place of death for most of participants. We also used computerized telephone lists in 1994, telephone books and residential maps in 1980 to get more information on the participants. In this study, we had a high follow-up rate (91.4%) and could specify the underlying causes of deaths in 98.3% of participants.
Since the original survey in 1980 was not designed for follow-up, several limitations should be kept in mind in interpreting the results. Risk factors were only observed once at the baseline survey, and changes in lifestyles or risk factor levels were not considered. Therefore, the risk of high blood pressure may be underestimated. We conducted a cause-specific mortality-based study using centrally coded national vital statistic data, which was not validated. This may also reduce the relationship between risk factors and disease occurrence since nonspecific causes occasionally appear on the death certificate. Our study design is a retrospective cohort study and some deaths in the early stage of the follow-up period may have been missed since the residential record is usually discarded 5 years after death or moving out. However, the follow-up rate was significantly higher in those who were 60 years or above in 1980 than those under 60 years reflecting the high moving out rate among the younger age group. Thus, loss of follow-up seems to be due to moving from the original address rather than to death in the early follow-up period. Moreover, mortality was similar in the Japanese population and the influence of loss of follow-up seems to be minimal.
The treatment rates with anti-hypertensive drugs among participants with hypertension (SBPX160 mmHg or DBFX95 mmHg or with antihypertensive treatment) were 45% for men and 57% for women. 8 Since BP may change with treatment and the same BP level with or without treatment may not imply the same mortality rate, the observed relationship between BP levels and mortality may be diluted, especially in women.
Effect of elevated BP on heart disease mortality
In this study, we used heart disease mortality as a category to estimate the overall effect of elevated BP on heart-related mortality since IHD mortality numbers were very small for both sexes. Since mortality from heart disease includes other non specific causes (ie, mortality from heart failure), the observed relationships may be diluted. Among men, the relationship of SBP levels to heart disease mortality was significant before and after adjustment of other risk factors, in good agreement with other reports on IHD incidence in Japan. 5, 6, 16 However, among women, no significant relationship was observed between elevated BP and mortality from heart disease. The percentage of heart failure in the heart disease was 70% in women (1987) while 66% among men (1987) in Japan, and this high percentage of nonspecific causes among women may be related to the lack of a relationship of elevated BP to heart disease mortality among women. 4 
Public health implication
Mortality from stroke among Japanese has decreased by 80% during the last 30 years with the continuous decline of BP levels and has now reached moderate rates. Their decline may be due to changes in lifestyles such as reduction in salt intake 3 as well as an increasing treatment rate among hypertensives. 8, 17 As shown in this report, elevated BP is still one of the leading causes of death among Japanese, while the impact of high BP shown in this study may be overestimated because of continuous declining trends after this baseline survey. 2, 3 Excess stroke mortality due to elevated BP is still high and efforts to reduce the BP level among Japanese should continue. Since mild hypertension is a major source of excess stroke death (Figure 1) , lifestyle modification should be emphasized for the whole population. We should also pay more attention to reducing other risk factors such as smoking and the continuing increase of serum total cholesterol levels among Japanese. 18 
